TrialClinics (Sao Paulo, Brazil)2017

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study.

Luciana Azevedo Callefi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.